$1.31
0.2321.4%
Last update: Aug 12, 11:12 AM
Dermata Therapeutics Inc
DRMANASDAQ
Earnings: Q2 2026 Earnings were released on Tue Aug 11th, after the market close
Dermata Therapeutics Market Sentiment
Market sentiment signals for Dermata Therapeutics (DRMA): analyst consensus, short interest, options flow and insider activity.
Key Signals
Analyst Consensus▲ Buy
Short Interest▲ 1.6% short float
Options Flow— N/A
Insider Activity— N/A
Analyst Consensus
Buy
1 analysts
Options Flow (P/C)
—
Avg Consensus PT
$10
+662.7%
Highest Price Target
$10
+662.7%
Maxim Group
Lowest Price Target
$10
+662.7%
Maxim Group
Short Interest
1.6%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
Recent Analyst Actions
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 21, 2025 | Maxim Group | Anthony Vendetti— | +662.7% | $30 → $10 | Maintained | Buy |
| May 21, 2025 | Maxim Group | Anthony Vendetti— | +128.8% | $6 → $3 | Maintained | Buy |
